211 related articles for article (PubMed ID: 26349301)
1. Implant-Assisted Intrathecal Magnetic Drug Targeting to Aid in Therapeutic Nanoparticle Localization for Potential Treatment of Central Nervous System Disorders.
Lueshen E; Venugopal I; Soni T; Alaraj A; Linninger A
J Biomed Nanotechnol; 2015 Feb; 11(2):253-61. PubMed ID: 26349301
[TBL] [Abstract][Full Text] [Related]
2. Intrathecal magnetic drug targeting using gold-coated magnetite nanoparticles in a human spine model.
Lueshen E; Venugopal I; Kanikunnel J; Soni T; Alaraj A; Linninger A
Nanomedicine (Lond); 2014; 9(8):1155-69. PubMed ID: 23862614
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal magnetic drug targeting for localized delivery of therapeutics in the CNS.
Venugopal I; Habib N; Linninger A
Nanomedicine (Lond); 2017 Apr; 12(8):865-877. PubMed ID: 28339319
[TBL] [Abstract][Full Text] [Related]
4. Computational Assessment of Unsteady Flow Effects on Magnetic Nanoparticle Targeting Efficiency in a Magnetic Stented Carotid Bifurcation Artery.
Hewlin RL; Smith M; Kizito JP
Cardiovasc Eng Technol; 2023 Oct; 14(5):694-712. PubMed ID: 37723333
[TBL] [Abstract][Full Text] [Related]
5. Computational and In Vitro Experimental Investigation of Intrathecal Drug Distribution: Parametric Study of the Effect of Injection Volume, Cerebrospinal Fluid Pulsatility, and Drug Uptake.
Tangen KM; Leval R; Mehta AI; Linninger AA
Anesth Analg; 2017 May; 124(5):1686-1696. PubMed ID: 28431428
[TBL] [Abstract][Full Text] [Related]
6. The use of magnetite nanoparticles for implant-assisted magnetic drug targeting in thrombolytic therapy.
Kempe M; Kempe H; Snowball I; Wallén R; Arza CR; Götberg M; Olsson T
Biomaterials; 2010 Dec; 31(36):9499-510. PubMed ID: 20732712
[TBL] [Abstract][Full Text] [Related]
7. Implantable and transdermal polymeric drug delivery technologies for the treatment of central nervous system disorders.
Govender T; Choonara YE; Kumar P; Bijukumar D; du Toit LC; Modi G; Naidoo D; Pillay V
Pharm Dev Technol; 2017 Jun; 22(4):476-486. PubMed ID: 27268737
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo accumulation of magnetic nanoporous silica nanoparticles on implant materials with different magnetic properties.
Janßen HC; Warwas DP; Dahlhaus D; Meißner J; Taptimthong P; Kietzmann M; Behrens P; Reifenrath J; Angrisani N
J Nanobiotechnology; 2018 Nov; 16(1):96. PubMed ID: 30482189
[TBL] [Abstract][Full Text] [Related]
9. Magnetic field distribution modulation of intrathecal delivered ketorolac iron-oxide nanoparticle conjugates produce excellent analgesia for chronic inflammatory pain.
Wu PC; Shieh DB; Hsiao HT; Wang JC; Lin YC; Liu YC
J Nanobiotechnology; 2018 May; 16(1):49. PubMed ID: 29769077
[TBL] [Abstract][Full Text] [Related]
10. Modelling the effect of SPION size in a stent assisted magnetic drug targeting system with interparticle interactions.
Mardinoglu A; Cregg PJ
ScientificWorldJournal; 2015; 2015():618658. PubMed ID: 25815370
[TBL] [Abstract][Full Text] [Related]
11. Design and Fabrication of Magnetically Responsive Nanocarriers for Drug Delivery.
Kralj S; Potrc T; Kocbek P; Marchesan S; Makovec D
Curr Med Chem; 2017; 24(5):454-469. PubMed ID: 27528059
[TBL] [Abstract][Full Text] [Related]
12. Numerical Simulation of Magnetic Drug Targeting to the Stenosis Vessel Using Fe
Badfar H; Yekani Motlagh S; Sharifi A
Cardiovasc Eng Technol; 2020 Apr; 11(2):162-175. PubMed ID: 31853904
[TBL] [Abstract][Full Text] [Related]
13. Tale of Two Magnets: An Advanced Magnetic Targeting System.
Zhou Z; Shen Z; Chen X
ACS Nano; 2020 Jan; 14(1):7-11. PubMed ID: 31869210
[TBL] [Abstract][Full Text] [Related]
14. Magnetically assisted intraperitoneal drug delivery for cancer chemotherapy.
Shamsi M; Sedaghatkish A; Dejam M; Saghafian M; Mohammadi M; Sanati-Nezhad A
Drug Deliv; 2018 Nov; 25(1):846-861. PubMed ID: 29589479
[TBL] [Abstract][Full Text] [Related]
15. Magnetic Nanoparticles in the Central Nervous System: Targeting Principles, Applications and Safety Issues.
D'Agata F; Ruffinatti FA; Boschi S; Stura I; Rainero I; Abollino O; Cavalli R; Guiot C
Molecules; 2017 Dec; 23(1):. PubMed ID: 29267188
[TBL] [Abstract][Full Text] [Related]
16. Use of magnetic fields and nanoparticles to trigger drug release and improve tumor targeting.
Liu JF; Jang B; Issadore D; Tsourkas A
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Nov; 11(6):e1571. PubMed ID: 31241251
[TBL] [Abstract][Full Text] [Related]
17. Magnetic Drug Targeting: A Novel Treatment for Intramedullary Spinal Cord Tumors.
Kheirkhah P; Denyer S; Bhimani AD; Arnone GD; Esfahani DR; Aguilar T; Zakrzewski J; Venugopal I; Habib N; Gallia GL; Linninger A; Charbel FT; Mehta AI
Sci Rep; 2018 Jul; 8(1):11417. PubMed ID: 30061692
[TBL] [Abstract][Full Text] [Related]
18. Investigation of magnetically driven passage of magnetic nanoparticles through eye tissues for magnetic drug targeting.
Zahn D; Klein K; Radon P; Berkov D; Erokhin S; Nagel E; Eichhorn M; Wiekhorst F; Dutz S
Nanotechnology; 2020 Dec; 31(49):495101. PubMed ID: 32946423
[TBL] [Abstract][Full Text] [Related]
19. Increased accumulation of magnetic nanoparticles by magnetizable implant materials for the treatment of implant-associated complications.
Angrisani N; Foth F; Kietzmann M; Schumacher S; Angrisani GL; Christel A; Behrens P; Reifenrath J
J Nanobiotechnology; 2013 Oct; 11():34. PubMed ID: 24112871
[TBL] [Abstract][Full Text] [Related]
20. Computational Modelling of Magnetic Nanoparticle Properties and In Vivo Responses.
Winkler DA
Curr Med Chem; 2017; 24(5):483-496. PubMed ID: 27758713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
